Please select the option that best describes you:

What is your approach to MRD testing in the frontline treatment of multiple myeloma?   

How frequently and what type of testing/sample are you performing MRD assessment?

Does your approach differ between transplant-eligible and transplant-ineligible patients?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Medical University of South Carolina
Could not agree more - for some reason (big pharma...
Sign in or Register to read more